Strength in numbers: Advancing the clinical reality fibroblast activation protein imaging in cardiovascular disease
- 3 August 2024
- journal article
- editorial
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 38, 102016
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- 99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applicationsEJNMMI Radiopharmacy and Chemistry, 2024
- Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided TherapyJournal of Nuclear Medicine, 2023
- Spatial multi-omic map of human myocardial infarctionNature, 2022
- Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional OutcomeJournal of Nuclear Medicine, 2022
- CAR T cells produced in vivo to treat cardiac injuryScience, 2022
- Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PETClinical Nuclear Medicine, 2021
- Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04Journal of Nuclear Cardiology, 2021
- Molecular Imaging Identifies Fibroblast Activation Beyond the Infarct Region After Acute Myocardial InfarctionJACC, 2021
- Prospective Evaluation of 18 F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional OutcomeCirculation: Cardiovascular Imaging, 2016
- Regional Myocardial Sympathetic Denervation Predicts the Risk of Sudden Cardiac Arrest in Ischemic CardiomyopathyJACC, 2014